Table of Content Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019) 2.2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million) Chapter 3 Prenatal and Newborn Genetic Testing Market Overview 3.1 Introduction and Market Definition 3.2 Future Market Outlook 3.3 Regulatory and Reimbursement Scenario for Prenatal and Newborn Screening 3.4 Market Dynamics 3.4.1 Drivers 3.4.2 Restraints 3.4.3 Market Opportunities 3.5 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis Visit at http://www.linkedin.com/today/post/article/20140505063456-173774513-prenatal-and-new-born-genetic-testing-market-size-growth-and-outlook-2019

1. Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013
- 2019
Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the
sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect
chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing
market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by
technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR),
fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as
non-invasive prenatal tests and maternal serum screening.
Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific
and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year,
have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market
report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.
The market overview section of the prenatal and newborn genetic testing market report discusses the market dynamics with respect to market drivers, restraints
and opportunities. This section also covers market attractiveness analysis (by geography) and Porter’s five forces analysis for the global prenatal and
newborn genetic testing market. Market share (%) for the major players operating in prenatal and newborn genetic testing market has also been provided for the
year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the
company profiles of key players operating in various segments of prenatal and newborn genetic testing market. Each company profile includes the business
overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the
prenatal and newborn genetic testing market that have been profiled in this report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and
Illumina, Inc.
table Of Content
chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.4 List Of Abbreviations
chapter 2 Executive Summary
2.1 Market Snapshot: Global Prenatal And Newborn Genetic Testing Market (2012 & 2019)
2.2 Global Prenatal And Newborn Genetic Testing Market, By Segments, 2012 (usd Million)
chapter 3 Prenatal And Newborn Genetic Testing Market Overview
3.1 Introduction And Market Definition
3.2 Future Market Outlook
3.3 Regulatory And Reimbursement Scenario For Prenatal And Newborn Screening
3.4 Market Dynamics
3.4.1 Drivers
3.4.2 Restraints
3.4.3 Market Opportunities
3.5 Porter’s Five Forces Analysis: Global Prenatal And Newborn Genetic Testing Market
3.5.1 Bargaining Power Of Suppliers
3.5.2 Bargaining Power Of Buyers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
chapter 4 Prenatal And Newborn Genetic Testing Market, By Technology
4.1 Overview
4.1.1 Global Prenatal And Newborn Genetic Testing Market Revenue, By Technology, 2012 – 2019 (usd Million)
4.2 Diagnostic Techniques
4.2.1 Global Diagnostic Techniques Market Revenue, By Types, 2012 – 2019 (usd Million)
4.2.2 Polymerase Chain Reaction (pcr)
4.2.3 Fluorescence In-situ Hybridization (fish)
4.2.4 Array-comparative Genomic Hybridization (acgh)
4.3 Screening Methods
4.3.1 Global Screening Methods Market Revenue, By Types, 2012 – 2019 (usd Million)
Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

2. 4.3.2 Non-invasive Prenatal Tests (maternit21 Plus, Verifi, Harmony, Panorama, Nifty, Prenatest And Bambni Test)
4.3.3 Maternal Serum Screening (mss)
chapter 5 Prenatal And Newborn Genetic Testing Market, By Geography
5.1 Overview
5.1.1 Global Prenatal And Newborn Genetic Testing Market Revenue, By Geography2012 – 2019 (usd Million)
5.2 North America
5.2.1 North America Prenatal And Newborn Genetic Testing Market Revenue, By Technology, 2012 - 2019 (usd Million)
5.2.2 North America Diagnostic Techniques Market Revenue, By Types, 2012 - 2019 (usd Million)
5.2.3 North America Screening Methods Market Revenue, By Types, 2012 - 2019 (usd Million)
5.3 Europe
5.3.1 Europe Prenatal And Newborn Genetic Testing Market Revenue, By Technology, 2012 - 2019 (usd Million)
5.3.2 Europe Diagnostic Techniques Market Revenue, By Types, 2012 - 2019 (usd Million)
5.3.3 Europe Screening Methods Market Revenue, By Types, 2012 - 2019 (usd Million)
5.4 Asia - Pacific
5.4.1 Asia-pacific Prenatal And Newborn Genetic Testing Market Revenue, By Technology, 2012 - 2019 (usd Million)
5.4.2 Asia-pacific Diagnostic Techniques Market Revenue, By Types, 2012 - 2019 (usd Million)
5.4.3 Asia-pacific Screening Methods Market Revenue, By Types, 2012 - 2019 (usd Million)
5.5 Rest Of The World (row)
5.5.1 Row Prenatal And Newborn Genetic Testing Market Revenue, By Technology, 2012 - 2019 (usd Million)
5.5.2 Row Diagnostic Techniques Market Revenue, By Types, 2012 - 2019 (usd Million)
5.5.3 Row Screening Methods Market Revenue, By Types, 2012 - 2019 (usd Million)
chapter 6 Competitive Landscape
6.1 Market Share Analysis, By Key Players, 2012 (%)
chapter 7 Recommendations
7.1 Market Strategy For Success
7.1.1 Focus On Forming Alliances With Diagnostic Service Providers In Asia-pacific Countries
7.1.2 Emphasis On Improving Technology In Order To Increase Accuracy, Reduce The Duration Of Result Generation And Price
7.2 Barriers And Future Assumptions
7.2.1 Lack Of Awareness About Prenatal And Newborn Genetic Testing In Some Asian Countries
7.2.2 Regulatory Compliance And Ethical Issues
chapter 8 Company Profiles
8.1 Agilent Technologies, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Ariosa Diagnostics, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Bio-rad Laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Laboratory Corporation Of America Holdings (labcorp)
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

3. 8.5.5 Recent Developments
8.6 Natera, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Perkinelmer, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Sequenom, Inc.
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019